Canonica G W, Caria M, Bagnasco M, Cosulich M E, Giordano G, Moretta L
Clin Immunol Immunopathol. 1985 Jul;36(1):40-8. doi: 10.1016/0090-1229(85)90037-6.
These experiments were designed to analyze the involvement of T-lymphocyte subpopulations in autoimmune thyroid disorders such as Graves' Disease (GD) and Hashimoto's Disease (HD). In a first set of experiments, lymphocytes isolated from thyroid infiltrates or from peripheral blood of GD and HD patients were analyzed for the expression of various surface antigens. While HLA-DR + T cells were numerous among thyroid infiltrating T lymphocytes in both groups of patients, the proportions of T8 + cells (as defined by their reactivity with the B 9.4 monoclonal antibody specific for T8 surface molecule) were strikingly different in HD and GD. In the latter group of patients only 19% of infiltrating T cells were T8 +, whereas these cells represented approximately 50% in four HD patients. Given the previous demonstration that all T cells expressing T8 antigen are cytolytic T lymphocytes (CTL) or their precursors (CTL-P) in conjunction with the fact that lymphocytes from HD or GD patients are known to proliferate in vitro in response to human tg (Htg), we further analyzed the T-cell subset(s) responsible for in vitro proliferation to Htg. In these experiments, peripheral blood T lymphocytes purified from patients with GD or HD were cultured with 1 microgram/ml Htg and irradiated autologous T-depleted mononuclear cells as the source of antigen presenting cells (APC). The proportions of T8 + cells declined considerably during culture in GD patients, but at Days 6 to 9, T8 + cells represented as much as 51% of cultured T lymphocytes from patients with HD. Moreover, the majority of T8 + cells were medium-large size lymphoblasts. Removal of Htg at Day 6 resulted in both abrogation of proliferative responsiveness and in decreases of T8 + percentages. Further analysis of the cell interactions leading to T8 + cell proliferation in response to Htg showed that helper/inducer T cells, as defined by 5/9 antigen expression, were strictly required. Collectively, these features are reminiscent of the T-cell involvement in experimental autoimmune thyroiditis of mice and stress for the first time the potential role of CTL in tissue damage occurring in Hashimoto's thyroiditis.
这些实验旨在分析T淋巴细胞亚群在自身免疫性甲状腺疾病(如格雷夫斯病(GD)和桥本氏病(HD))中的作用。在第一组实验中,对从GD和HD患者的甲状腺浸润物或外周血中分离出的淋巴细胞进行了各种表面抗原表达的分析。虽然两组患者的甲状腺浸润性T淋巴细胞中HLA-DR + T细胞数量众多,但HD和GD中T8 +细胞的比例(由它们与针对T8表面分子的B 9.4单克隆抗体的反应性定义)却显著不同。在后者患者组中,只有19%的浸润性T细胞是T8 +,而在四名HD患者中这些细胞约占50%。鉴于先前已证明所有表达T8抗原的T细胞都是细胞毒性T淋巴细胞(CTL)或其前体(CTL-P),再结合已知HD或GD患者的淋巴细胞在体外对人甲状腺球蛋白(Htg)有增殖反应这一事实,我们进一步分析了负责体外对Htg增殖的T细胞亚群。在这些实验中,将从GD或HD患者纯化的外周血T淋巴细胞与1微克/毫升Htg以及经辐照的自体T细胞耗竭的单核细胞一起培养,后者作为抗原呈递细胞(APC)的来源。在GD患者的培养过程中,T8 +细胞的比例大幅下降,但在第6至9天,HD患者培养的T淋巴细胞中T8 +细胞占比高达51%。此外,大多数T8 +细胞是中等大小至大的淋巴母细胞。在第6天去除Htg导致增殖反应消失以及T8 +百分比下降。对导致T8 +细胞对Htg增殖的细胞相互作用的进一步分析表明,由5/9抗原表达定义的辅助/诱导T细胞是严格必需的。总的来说,这些特征让人联想到T细胞在小鼠实验性自身免疫性甲状腺炎中的作用,并首次强调了CTL在桥本氏甲状腺炎组织损伤中的潜在作用。